[Effects of levonorgestrel intrauterine system on the expressions of estrogen receptor, progesterone receptor and insulin-like growth factor-1]

Zhonghua Yi Xue Za Zhi. 2014 Sep 23;94(35):2763-5.
[Article in Chinese]

Abstract

Objective: To explore the effects of levonorgestrel intrauterine system on estrogen receptor (ER) and progesterone receptor (PR), insulin-like growth factor-1 (IGF-1) of endometrial polyps and surrounding endometrial tissue.

Methods: A total of 250 cases of hysteroscopic resection for endometrial polyps were divided into study group (n = 125) with placement of levonorgestrel intrauterine system after hysteroscopic electroresection and control group (n = 125) without placement. The intraoperative and postoperative expressions of ER, PR and IGF-1 in endometrial biopsy specimens were measured by immunohistochemistry. They were followed up for 2 years to analyze the recurrence of endometrial polyp.

Results: All patients had successful surgery. When intraoperative and postoperative specimens were compared with regards to the expressions of ER, PR and IGF-1, significant differences existed between two groups. During a 2-year follow-up, the recurrence of endometrial polyp was 10.89% in control group versus 0 in study group.

Conclusion: Levonorgestrel intrauterine system may inhibit the recurrence and formation of endometrial polyp through lowering the expressions of ER, PR and IGF-1.

MeSH terms

  • Female
  • Humans
  • Immunohistochemistry
  • Insulin-Like Growth Factor I
  • Intrauterine Devices, Medicated
  • Levonorgestrel / therapeutic use*
  • Neoplasm Recurrence, Local
  • Polyps
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Somatomedins
  • Uterine Neoplasms

Substances

  • Receptors, Estrogen
  • Receptors, Progesterone
  • Somatomedins
  • Levonorgestrel
  • Insulin-Like Growth Factor I